Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease. Issue 11 (26th October 2007)

• Record Type: Journal Article
• Authors: Cohen, R D; Bowie, W R; Enns, R; Flint, J; Fitzgerald, J M
• Is Part Of: Thorax. Volume 62:Issue 11(2007)
• Page Start: 1013
• Page End: 1014
• Publication Date: 2007-10-26
• Subjects: Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thx.2006.075150
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : The use of anti-tumour necrosis factor (TNF) agents has expanded significantly over the past few years, particularly for rheumatological diseases and Crohn's disease. A number of associated opportunistic infections have been observed as a result of suppression of T cell-mediated immunity, the most frequent being tuberculosis. We report the first case of pulmonary actinomycosis in a patient receiving regular infusions of infliximab, an anti-TNF agent, for Crohn's disease.